Taha Qazi, MD: Male Sexual Dysfunction Following Ulcerative Colitis Surgery

Video

Patients who have IPAA are more than twice as likely to suffer from male sexual dysfunction.

New research indicates that male sexual dysfunction is more common in patients with restorative ileo anal pouch anastomosis (IPAA) after proctocolectomy, a surgery commonly used for patients with ulcerative colitis, than it is in the general population.

In an interview with HCPLive® during the 2022 Digestive Disease Week (2022) Annual Meeting in San Diego, Taha Qazi, MD, Gastroenterology, Hepatology, and Nutrition, Cleveland Clinic, explained the results of a new study and what the knowledge of an increased risk of male sexual dysfunction can do for patients.

Qazi said that male sexual dysfunction is likely more common in these patients because of nerve damage caused by the surgery.

Overall, males who have this surgery have twice as likely chance of having male sexual dysfunction.

“This is something that’s common,” Qazi said. “One of the things we don’t talk about as clinicians and physicians is male sexual dysfunction with our patients.”

He said the data should give clinicians comfort to begin conversations with patients because it might be more common than previously believed.

The study, which looked at more than 40,000 patients with ulcerative colitis who had IPAA found 1940 cases of male sexual dysfunction. However, Qazi said the surgery is absolutely necessary for many and the sexual dysfunction can be treated with available medications.

Recent Videos
Arshad Khanani, MD: Four-Year Outcomes of Faricimab for DME in RHONE-X | Image Credit: Sierra Eye Associates
Dilraj Grewal, MD: Development of MNV in Eyes with Geographic Atrophy in GATHER | Image Credit: Duke Eye Center
Margaret Chang, MD: Two-Year Outcomes of the PDS for Diabetic Retinopathy | Image Credit: Retina Consultants Medical Group
Carl C. Awh, MD: | Image Credit:
Raj K. Maturi, MD: 4D-150 for nAMD in PRISM Population Extension Cohort | Image Credit: Retina Partners Midwest
Charles C. Wykoff, MD, PhD: Interim Analysis on Ixo-Vec Gene Therapy for nAMD | Image Credit: Retina Consultants of Texas
Sunir J. Garg, MD: Pegcetacoplan Preserves Visual Function on Microperimetry | Image Credit: Wills Eye Hospital
Edward H. Wood, MD: Pharmacodynamics of Subretinal RGX-314 for Wet AMD | Image Credit: Austin Retina Associates
Dilsher Dhoot, MD: OTX-TKI for NPDR in Interim Phase 1 HELIOS Results  | Image Credit: LinkedIn
Katherine Talcott, MD: Baseline EZ Integrity Features Predict GA Progression | Image Credit: LinkedIn
© 2024 MJH Life Sciences

All rights reserved.